• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=22850568).
  

PubMed=20099279; DOI=10.1002/ijc.25182
Kholmanskikh O., van Baren N., Brasseur F., Ottaviani S., Vanacker J., Arts N., van der Bruggen P., Coulie P.G., De Plaen E.
Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens.
Int. J. Cancer 127:1625-1636(2010)

PubMed=22850568; DOI=10.1158/1078-0432.CCR-12-1632; PMCID=PMC3463754
Khalili J.S., Liu S.-J., Rodriguez-Cruz T.G., Whittington M., Wardell S., Liu C.-W., Zhang M.-Y., Cooper Z.A., Frederick D.T., Li Y.-F., Zhang M., Joseph R.W., Bernatchez C., Ekmekcioglu S., Grimm E.A., Radvanyi L.G., Davis R.E., Davies M.A., Wargo J.A., Hwu P., Lizee G.A.
Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma.
Clin. Cancer Res. 18:5329-5340(2012)